go back

Revefenacin (Yupelri) Inhalation Solution

New Jersey rates for HCPCS J7677

Revefenacin inhalation solution, FDA-approved final product, noncompounded, administered through DME, 1 mcg

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$10,4710%20%10th90th$0Professionalmedian $0 · 10th–90th $0$00%50%90th$0$0.0$0.2$2.0$20.0$200.0$2.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.26
Median
$0.30
Typical High
$0.55
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.20
Median
$0.20
Typical High
$0.28
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.20
Median
$0.22
Typical High
$0.32
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.20
Median
$0.20
Typical High
$0.32
Emblem Health
Setting
Professional
Modifier
Global
Typical Low
$0.17
Median
$0.21
Typical High
$0.32
Horizon BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.50
Median
$11,481.54
Typical High
$25,118.86
Horizon BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.19
Median
$0.20
Typical High
$0.30
United
Setting
Facility
Modifier
Global
Typical Low
$0.08
Median
$0.36
Typical High
$0.42
United
Setting
Professional
Modifier
Global
Typical Low
$0.08
Median
$0.20
Typical High
$0.24